Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / France

Research and Innovation Action · Running

PROACT EU-Response A European Proactive Adaptive Clinical Trials Network within EU-Response

Coordinator
Institut National De La Sante Et De La Recherche Medicale, France
Runs
1 January 2025 to 31 December 2029
Status
Running
EU funding
€17.0m
Total cost
—
Partners
26 organisations in 10 countries
Type
Research and Innovation Action
Grant agreement
101156304

What the project is doing

In the project's own words, from its summary on CORDIS.

Recent pandemics showed Europe how serious health threats can be to society. Proactive approaches are needed to ensure that medical countermeasures are available during pandemics. PROACT EU-Response’s overarching objective is to prepare Europe for future pandemics by strengthening upon existing networks of experts and civil society focused on clinical therapeutic platform trials within hospital inpatient settings across Europe.

In case of an outbreak, this network will provide capacity to pivot rapidly to implement large, multi-country platform trials studying therapeutics and diagnostic-tool performance. Underpinned by strong community involvement and further strengthened by the inclusion of social and implementation scientists, PROACT EU-Response centres on six objectives: expand a solid network of clinical centres across Europe that will implement a clinical trial assessing a syndromic approach for respiratory viral infections; strengthen a laboratory network to identify pathogens and biomarkers of disease monitoring for routine surveillance; support a network of methodologists and trialists who will ensure the trials’ logistical and methodological aspects; initiate a network of professionals to work on preparedness tools to ensure a smooth pivot from inter-pandemic to the pandemic period in case of an outbreak; build a network of social science researchers who will provide nuanced understanding of the social contexts; and establish a community group to work on activities that will empower patients and citizens in Europe regarding their own health and educate them about science and health issues.

By bringing together scientists, social science researchers, and civil society members, PROACT EU-Response will benefit the entire European population and beyond through decreased mortality and morbidity associated with emerging diseases, lower societal economic costs of morbidity, strengthened research and innovation expertise, human capacities, and know-how for combatting communicable diseases.

Topics

Who is involved

OrganisationCityCountryRole
Institut National De La Sante Et De La Recherche MedicaleParisFranceCoordinator
Medizinische Universitaet WienWienAustriaParticipant
Forum Des Patients EuropeensBruxelles / BrusselBelgiumParticipant
Universite Libre De BruxellesBruxellesBelgiumParticipant
Universiteit AntwerpenAntwerpenBelgiumParticipant
Universitat BaselBaselSwitzerlandAssociatedpartner
Fundacion Para La Investigacion Biomedica Del Hospital Universiatrio La PazMadridSpainThird party
Servicio Madrileno De SaludMadridSpainParticipant
Assistance Publique Hopitaux De ParisParisFranceParticipant
Biomerieux SAMarcy-l'EtoileFranceParticipant
Centre National De La Recherche Scientifique CNRSParisFranceParticipant
Collectif No FakemedPoitiersFranceParticipant
Ecrin European Clinical Research Infrastructure NetworkParisFranceParticipant
Hospices Civils De LyonLyonFranceParticipant
Inserm Transfert SAParisFranceParticipant
Les MarkabiensTrappesFranceParticipant
NileParisFranceParticipant
Sorbonne UniversiteParisFranceThird party
University College Dublin, National University of Ireland, DublinDublinIrelandParticipant
University of GalwayGalwayIrelandParticipant
Universita Degli Studi Di VeronaVeronaItalyParticipant
Stichting Nederlandse Wetenschappelijk Onderzoek InstitutenUtrechtNetherlandsParticipant
Oslo Universitetssykehus HfOsloNorwayParticipant
University College LondonLondonUnited KingdomParticipant
University of BristolBristolUnited KingdomParticipant
University of LancasterLancasterUnited KingdomParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI